Companies: 10,795·Total market cap: $144.5T
Orchard Therapeutics plc

Orchard Therapeutics plc

ORTXNASDAQHealthcare
$16.70
+$0.05(+0.30%)
Market Cap$380108700
P/E Ratio
52W High$16.72
52W Low$4.24
Overview

Orchard Therapeutics plc(ORTX)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · ORTX · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2022-122021-122020-122019-122018-12
Revenue
Revenue$6.99M$0.48M$2.60M$2.51M$2.08M
Cost of Revenue$2.43M$0.23M$0.86M$0.81M$0.42M
Gross Profit$4.55M$0.26M$1.74M$1.71M$1.65M
Gross Margin %(computed)65.17%53.21%66.97%67.97%79.67%
Operating Expenses
R&D Expenses$25.55M$23.35M$93.73M$117.36M$205.32M
G&A Expenses$44.66M$49.65M$56.89M$49.16M$0.00M
Total Operating Expenses$36.15M$36.90M$158.72M$174.58M$236.69M
Operating Income($31.59M)($36.41M)($156.98M)($172.87M)($235.03M)
Operating Margin %(computed)-452.22%
Interest Income$0.86M$0.06M$3.19M$7.36M$0.00M
Interest Expense$0.93M$0.68M$2.33M$1.54M$0.00M
Income Before Tax($9.01M)($36.22M)($152.71M)($165.66M)($229.53M)
Income Tax Expense($1.13M)$0.13M($0.73M)($2.24M)$0.97M
Net Income($7.88M)($36.35M)($151.98M)($163.42M)($230.50M)
Net Margin %(computed)-112.84%
Per Share & EBITDA
EPS (Basic)$-0.61$-2.93$-15.28$-17.53$-102.17
Wtd Avg Shares12.80M12.40M9.94M9.32M2.26M
EBITDA($8.08M)($35.54M)($148.38M)($155.38M)($235.03M)
EBITDA Margin %(computed)-115.65%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解Orchard Therapeutics plc

关于Orchard Therapeutics plc(ORTX)损益表

Orchard Therapeutics plc(ORTX)损益表数据来源于SEC Form 10-K及10-Q申报文件。2022财年,ORTX实现营收$0.01B,毛利润$0.00B(毛利率65.17%),净利润($0.01B)(净利率-112.84%)。

常见问题

ORTX · 4 问

Orchard Therapeutics plc(ORTX)2022财年营收为$0.01B,同比up1346.4%。

ORTX revenueORTX salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09